A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
NCT07545759
This study is recruiting at 14 US sites in 10 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to evaluate how well brenipatide (LY3537031) is tolerated, what side effects may occur, and the safety and efficacy in participants with Irritable Bowel Syndrome-Diarrhea (IBS-D). The study drug will be administered subcutaneously (SC) (under the skin) when compared with placebo. The study will last approximately 36 weeks.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Irritable Bowel Syndrome
- Diarrhea
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Eli Lilly and Company
- Last updated on ClinicalTrials.gov
- October 8, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arizona · 1
- Del Sol Research Management - Mesa · Mesa, AZ
California · 3
- Smart Cures Clinical Research · Anaheim, CA
- Om Research LLC · Lancaster, CA
- United Medical Doctors - Los Alamitos · Los Alamitos, CA
Florida · 2
- Encore Medical Research · Hollywood, FL
- Clinical Research of Osceola · Kissimmee, FL
Illinois · 1
- Springfield Clinic - First · Springfield, IL
Indiana · 1
- Gastroenterology Health Partners · New Albany, IN
Kentucky · 1
- Gastroenterology Health Partners · Louisville, KY
Michigan · 1
- Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinical Research Center · Wyoming, MI
Ohio · 1
- Ohio Gastroenterology · Columbus, OH
Rhode Island · 1
- University Gastroenterology · Providence, RI
Texas · 2
- Biopharma Informatic, LLC · McAllen, TX
- Southern Star Research Institute · San Antonio, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.